GGrantIndex
Sort

17,828 grants matching crispr

NSF Postdoctoral Fellowship in Biology FY 2021: Understanding the genetic and physiologic adaptations to thermally challenging environments in Chinook Salmon.

$207,000
Bradford Dimos · Dimos, Bradford · · FY2021 · BIO

Profiling and perturbing the inheritance of drug-induced metabolic states in cancer with Inheritance-Seq

$206,955
Paul Clark Blainey · Broad Institute, Inc. · R61 · FY2025 · CA

Multicell type human liver on chip microphysiological platform to examine CRISPR based gene modulation

$206,728
Samira Kiani · University Of Pittsburgh At Pittsburgh · U01 · FY2019 · EB

Epigenetic and Genetic Vulnerabilities in Synovial Sarcoma

$206,686
Marc Ladanyi · Sloan-Kettering Inst Can Research · P50 · FY2023 · CA

Engineering non-proliferating-but-active (NPBA) probiotic for breast-cancer gene therapy

$206,627
Cheemeng Tan · University Of California At Davis · R21 · FY2022 · CA

Rapid, cost-effective whole genome screening tools for cryptic inversions and translocations

$206,597
Christopher John Tompkins · Kromatid, Inc. · R44 · FY2018 · HG

MOLECULAR MECHANISMS UNDERLYING INTELLECTUAL DISABILITY CAUSED BY MUTATIONS IN THE CHROMATIN MODIFIER KDM5C

$206,532
Julie Secombe · Albert Einstein College Of Medicine · P50 · FY2023 · HD

MOLECULAR MECHANISMS UNDERLYING INTELLECTUAL DISABILITY CAUSED BY MUTATIONS IN THE CHROMATIN MODIFIER KDM5C

$206,532
Julie Secombe · Albert Einstein College Of Medicine · P50 · FY2022 · HD

MOLECULAR MECHANISMS UNDERLYING INTELLECTUAL DISABILITY CAUSED BY MUTATIONS IN THE CHROMATIN MODIFIER KDM5C

$206,532
Julie Secombe · Albert Einstein College Of Medicine · P50 · FY2024 · HD

MOLECULAR MECHANISMS UNDERLYING INTELLECTUAL DISABILITY CAUSED BY MUTATIONS IN THE CHROMATIN MODIFIER KDM5C

$206,532
Julie Secombe · Albert Einstein College Of Medicine · P50 · FY2025 · HD

Identification of Resistance Mechanisms to Anaplastic Lymphoma Kinase Inhibitors (Diversity Supplement)

$206,413
Alice T Shaw · Massachusetts General Hospital · R01 · FY2018 · CA

Metabolic compensation in Mycobacterium tuberculosis for the formation of persisters

$206,250
Hyungjin Eoh · University Of Southern California · R21 · FY2020 · AI

Mammalian cell modulation of iron availability for an intravacuolar pathogen

$206,250
Ralph R Isberg · Tufts University Boston · R21 · FY2016 · AI

Development of a wound-on-chip model to study stromal-epithelial interactions during tissue repair

$206,250
Jeroen Eyckmans · Boston University (Charles River Campus) · R21 · FY2022 · EB

CRISPR-Cas13d: Transgenic zebrafish lines toknockdown mRNA

$206,250
Ariel Bazzini · Stowers Institute For Medical Research · R21 · FY2023 · OD

Identifying epigenetic states of TADs and targeting using epigenome editing

$206,250
Suhn Kyong Rhie · University Of Southern California · R21 · FY2023 · HG

Regulation of sex differences in liver metabolism

$206,250
David J Waxman · Boston University (Charles River Campus) · R56 · FY2018 · DK

Identifying epigenetic states of TADs and targeting using epigenome editing

$206,250
Suhn Kyong Rhie · University Of Southern California · R21 · FY2021 · HG

Identifying epigenetic states of TADs and targeting using epigenome editing

$206,250
Suhn Kyong Rhie · University Of Southern California · R21 · FY2022 · HG

Pou4f3 enhancers in hearing loss treatment

$206,209
Litao Tao · Creighton University · P20 · FY2024 · GM

Genetic Models Core

$206,200
Qiang Fu · Univ Of Arkansas For Med Scis · P20 · FY2025 · GM

Identification of Mycobacterium tuberculosis-derived metabolites acting as ligands for MR1-restricted T cells.

$206,200
Charles Kyriakos Vorkas · State University New York Stony Brook · R21 · FY2024 · AI

Role of Phosporylated SOX9 in Systemic Sclerosis Pathogenesis

$205,920
Sonsoles Piera-Velazquez · Thomas Jefferson University · R21 · FY2017 · AR

Pathogenic mechanisms of sinonasal sarcoma, a novel gender dimorphic cancer

$205,700
Margaret Mary Chou · Children'S Hosp Of Philadelphia · R21 · FY2021 · CA

Mechanisms of Chromosomal Translocation

$205,688
Peter Aplan · Division Of Clinical Sciences - Nci · ZIA · FY2023 · CA